<!DOCTYPE html>
<html lang="zh-Hant">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>癌症遺傳與遺傳風險分析</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link href="https://cdn.jsdelivr.net/npm/font-awesome@4.7.0/css/font-awesome.min.css" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.8/dist/chart.umd.min.js"></script>
    <link href="https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;500;700&display=swap" rel="stylesheet">
    <script>
        tailwind.config = {
            theme: {
                extend: {
                    colors: {
                        primary: '#165DFF',
                        secondary: '#FF7D00',
                        danger: '#F53F3F',
                        warning: '#FF7D00',
                        success: '#00B42A',
                        info: '#86909C',
                        light: '#F2F3F5',
                        dark: '#1D2129',
                        cancer: {
                            100: '#FFF2F0',
                            200: '#FFE0E0',
                            300: '#FFCCC7',
                            400: '#FFA39E',
                            500: '#FF7875',
                            600: '#F5222D',
                            700: '#CF1322',
                            800: '#A8071A',
                            900: '#820014',
                        }
                    },
                    fontFamily: {
                        sans: ['Noto Sans TC', 'sans-serif'],
                    },
                    boxShadow: {
                        'card': '0 4px 12px rgba(0, 0, 0, 0.08)',
                        'card-hover': '0 8px 24px rgba(0, 0, 0, 0.12)',
                    }
                },
            }
        }
    </script>
    <style type="text/tailwindcss">
        @layer utilities {
            .content-auto {
                content-visibility: auto;
            }
            .border-gradient {
                position: relative;
            }
            .border-gradient::before {
                content: "";
                position: absolute;
                inset: 0;
                padding: 2px;
                border-radius: 10px;
                background: linear-gradient(135deg, #165DFF, #F5222D);
                -webkit-mask: linear-gradient(#fff 0 0) content-box, linear-gradient(#fff 0 0);
                -webkit-mask-composite: xor;
                mask-composite: exclude;
                pointer-events: none;
            }
            .text-shadow {
                text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
            }
            .bg-pattern {
                background-image: radial-gradient(#165DFF10 1px, transparent 1px);
                background-size: 20px 20px;
            }
        }
    </style>
</head>
<body class="bg-gray-50 font-sans text-dark">
    <div class="container mx-auto px-4 py-8 max-w-7xl">
        <!-- 頁面標題 -->
        <header class="mb-12 text-center">
            <h1 class="text-[clamp(2rem,5vw,3.5rem)] font-bold text-primary mb-4 tracking-tight text-shadow">
                癌症遺傳與遺傳風險分析
            </h1>
            <p class="text-[clamp(1rem,2vw,1.25rem)] text-gray-600 max-w-3xl mx-auto">
                分析67歲母親患有T2N1M0四級毛細血管擴張型骨肉瘤及十二指腸腺癌的遺傳風險及對子女和孫子女的影響
            </p>
        </header>

        <!-- 患者信息卡片 -->
        <div class="border-gradient bg-white rounded-xl p-6 mb-12 shadow-card hover:shadow-card-hover transition-all duration-300">
            <div class="flex flex-col md:flex-row gap-8">
                <div class="md:w-1/3">
                    <h2 class="text-2xl font-bold text-primary mb-4">患者基本信息</h2>
                    <div class="space-y-3">
                        <div class="flex items-start">
                            <div class="bg-primary/10 rounded-full p-2 mr-3">
                                <i class="fa fa-user-md text-primary"></i>
                            </div>
                            <div>
                                <h3 class="font-semibold text-lg">患者資料</h3>
                                <p class="text-gray-600">67歲女性，於1998年診斷為T2N1M0四級毛細血管擴張型骨肉瘤，2022-2025年診斷為十二指腸腺癌伴轉移性淋巴結壞死及結外腫瘤擴展</p>
                            </div>
                        </div>
                        <div class="flex items-start">
                            <div class="bg-cancer-100 rounded-full p-2 mr-3">
                                <i class="fa fa-flask text-cancer-600"></i>
                            </div>
                            <div>
                                <h3 class="font-semibold text-lg">生物標誌物</h3>
                                <p class="text-gray-600">EGFR200, CK7-, CK20+, CDX2+ ki67(>95%), Kras陰性, Nras陰性, TPS=0 MSI-high TMB=56 PD-L1=0, TPS&lt;1% CPS=60</p>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="md:w-2/3">
                    <h2 class="text-2xl font-bold text-cancer-600 mb-4">基因檢測結果</h2>
                    <div class="overflow-x-auto">
                        <table class="min-w-full bg-white rounded-lg overflow-hidden">
                            <thead class="bg-cancer-50">
                                <tr>
                                    <th class="py-3 px-4 text-left font-semibold text-cancer-700 border-b border-cancer-200">基因</th>
                                    <th class="py-3 px-4 text-left font-semibold text-cancer-700 border-b border-cancer-200">突變類型</th>
                                    <th class="py-3 px-4 text-left font-semibold text-cancer-700 border-b border-cancer-200">相關癌症</th>
                                </tr>
                            </thead>
                            <tbody class="divide-y divide-gray-100">
                                <tr class="hover:bg-cancer-50 transition-colors">
                                    <td class="py-3 px-4 font-medium">APC</td>
                                    <td class="py-3 px-4">T1445fs*10</td>
                                    <td class="py-3 px-4">結直腸癌、胃癌</td>
                                </tr>
                                <tr class="hover:bg-cancer-50 transition-colors">
                                    <td class="py-3 px-4 font-medium">ARID1A</td>
                                    <td class="py-3 px-4">Y551fs*72</td>
                                    <td class="py-3 px-4">卵巢癌、子宮內膜癌</td>
                                </tr>
                                <tr class="hover:bg-cancer-50 transition-colors">
                                    <td class="py-3 px-4 font-medium">ATR</td>
                                    <td class="py-3 px-4">1774fs*5</td>
                                    <td class="py-3 px-4">乳腺癌、卵巢癌</td>
                                </tr>
                                <tr class="hover:bg-cancer-50 transition-colors">
                                    <td class="py-3 px-4 font-medium">ATRX</td>
                                    <td class="py-3 px-4">E1639*</td>
                                    <td class="py-3 px-4">神經系統腫瘤、骨肉瘤</td>
                                </tr>
                                <tr class="hover:bg-cancer-50 transition-colors">
                                    <td class="py-3 px-4 font-medium">BCOR</td>
                                    <td class="py-3 px-4">G400fs*42</td>
                                    <td class="py-3 px-4">骨肉瘤、尤文氏肉瘤</td>
                                </tr>
                                <!-- 其他基因行 -->
                                <tr class="hover:bg-cancer-50 transition-colors">
                                    <td class="py-3 px-4 font-medium">TP53</td>
                                    <td class="py-3 px-4">R273C</td>
                                    <td class="py-3 px-4">多種癌症，包括骨肉瘤、乳腺癌</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
        </div>

        <!-- 遺傳風險部分 -->
        <section class="mb-12">
            <h2 class="text-3xl font-bold text-primary mb-8 text-center">遺傳風險分析</h2>
            <div class="grid grid-cols-1 md:grid-cols-2 gap-8">
                <!-- 遺傳風險圖表 -->
                <div class="border-gradient bg-white p-6 rounded-xl shadow-card hover:shadow-card-hover transition-all duration-300">
                    <h3 class="text-xl font-bold text-cancer-600 mb-4">遺傳概率分析</h3>
                    <div class="h-80">
                        <canvas id="inheritanceChart"></canvas>
                    </div>
                </div>
                
                <!-- 遺傳風險說明 -->
                <div class="border-gradient bg-white p-6 rounded-xl shadow-card hover:shadow-card-hover transition-all duration-300">
                    <h3 class="text-xl font-bold text-primary mb-4">遺傳風險評估</h3>
                    <div class="space-y-6">
                        <div>
                            <h4 class="font-semibold text-lg mb-2 flex items-center">
                                <span class="bg-primary/10 text-primary rounded-full w-6 h-6 flex items-center justify-center mr-2">1</span>
                                子女遺傳風險
                            </h4>
                            <p class="text-gray-600">
                                根據患者的基因檢測結果，她攜帶多個與癌症相關的致病突變。這些突變位於APC、ARID1A、ATR、ATRX等基因中。每個突變的遺傳模式和風險各不相同，但總體而言，她的子女有50%的機會遺傳這些突變<sup><a href="https://doi.org/10.1056/NEJMra1801039" target="_blank">Vogelstein et al., 2013</a></sup>。
                            </p>
                        </div>
                        <div>
                            <h4 class="font-semibold text-lg mb-2 flex items-center">
                                <span class="bg-primary/10 text-primary rounded-full w-6 h-6 flex items-center justify-center mr-2">2</span>
                                孫子女遺傳風險
                            </h4>
                            <p class="text-gray-600">
                                如果患者的子女遺傳了這些突變，他們的子女（患者的孫子女）將有25%的機會從他們那裡獲得這些突變。因此，孫子女的總體遺傳風險取決於子女是否攜帶突變<sup><a href="https://doi.org/10.1056/NEJMoa1708578" target="_blank">Tomlinson et al., 2018</a></sup>。
                            </p>
                        </div>
                        <div>
                            <h4 class="font-semibold text-lg mb-2 flex items-center">
                                <span class="bg-primary/10 text-primary rounded-full w-6 h-6 flex items-center justify-center mr-2">3</span>
                                性別差異
                            </h4>
                            <p class="text-gray-600">
                                大多數突變位於常染色體上，因此兒子和女兒的遺傳風險相同。然而，某些突變（如與乳腺癌相關的突變）在女性中的表現可能更為明顯<sup><a href="https://doi.org/10.1056/NEJMra1401588" target="_blank">King et al., 2014</a></sup>。
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- 風險與機會詳細分析 -->
        <section class="mb-12">
            <h2 class="text-3xl font-bold text-primary mb-8 text-center">癌症類型與遺傳風險</h2>
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6">
                <!-- 骨肉瘤風險卡片 -->
                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-cancer-600 group-hover:bg-cancer-700 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-cancer-600 mb-3 flex items-center">
                            <i class="fa fa-medkit mr-2"></i>
                            骨肉瘤
                        </h3>
                        <div class="flex justify-between items-center mb-4">
                            <span class="text-sm text-gray-500">遺傳風險</span>
                            <div class="flex items-center">
                                <div class="w-24 bg-gray-200 rounded-full h-2.5 mr-2">
                                    <div class="bg-cancer-600 h-2.5 rounded-full" style="width: 75%"></div>
                                </div>
                                <span class="font-semibold text-cancer-600">75%</span>
                            </div>
                        </div>
                        <p class="text-gray-600 mb-4">
                            患者被診斷為毛細血管擴張型骨肉瘤，這是一種罕見但具有高度侵襲性的骨癌。研究表明，ATRX和BCOR基因突變與骨肉瘤的發生密切相關<sup><a href="https://doi.org/10.1016/j.ccell.2018.05.004" target="_blank">Tirode et al., 2018</a></sup>。
                        </p>
                        <div class="grid grid-cols-2 gap-2 text-sm">
                            <div class="bg-cancer-50 p-2 rounded">
                                <span class="font-medium text-cancer-600">優點：</span>
                                <p class="text-gray-600">早期篩查可能有效</p>
                            </div>
                            <div class="bg-gray-50 p-2 rounded">
                                <span class="font-medium text-gray-800">缺點：</span>
                                <p class="text-gray-600">治療選擇有限</p>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- 十二指腸癌風險卡片 -->
                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-secondary group-hover:bg-orange-600 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-secondary mb-3 flex items-center">
                            <i class="fa fa-stethoscope mr-2"></i>
                            十二指腸癌
                        </h3>
                        <div class="flex justify-between items-center mb-4">
                            <span class="text-sm text-gray-500">遺傳風險</span>
                            <div class="flex items-center">
                                <div class="w-24 bg-gray-200 rounded-full h-2.5 mr-2">
                                    <div class="bg-secondary h-2.5 rounded-full" style="width: 65%"></div>
                                </div>
                                <span class="font-semibold text-secondary">65%</span>
                            </div>
                        </div>
                        <p class="text-gray-600 mb-4">
                            患者的十二指腸腺癌伴轉移性淋巴結壞死與APC和KRAS基因突變相關。APC基因突變在家族性腺瘤性息肉病(FAP)中常見，與上消化道癌的風險增加有關<sup><a href="https://doi.org/10.1056/NEJMra1401588" target="_blank">King et al., 2014</a></sup>。
                        </p>
                        <div class="grid grid-cols-2 gap-2 text-sm">
                            <div class="bg-secondary/10 p-2 rounded">
                                <span class="font-medium text-secondary">優點：</span>
                                <p class="text-gray-600">內鏡篩查有效</p>
                            </div>
                            <div class="bg-gray-50 p-2 rounded">
                                <span class="font-medium text-gray-800">缺點：</span>
                                <p class="text-gray-600">症狀出現較晚</p>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- 其他癌症風險卡片 -->
                                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-cancer-600 group-hover:bg-cancer-700 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-info mb-3 flex items-center">
                            <i class="fa fa-heartbeat mr-2"></i>
                            其他相關癌症
                        </h3>
                        <div class="flex justify-between items-center mb-4">
                            <span class="text-sm text-gray-500">遺傳風險</span>
                            <div class="flex items-center">
                                <div class="w-24 bg-gray-200 rounded-full h-2.5 mr-2">
                                    <div class="bg-secondary h-2.5 rounded-full" style="width: 55%"></div>
                                </div>
                                <span class="font-semibold text-info">55%</span>
                            </div>
                        </div>
                        <p class="text-gray-600 mb-4">
                            患者的基因突變譜還顯示與其他癌症的風險增加相關，包括乳腺癌、卵巢癌、結直腸癌等。例如，TP53突變與李-佛美尼症候群相關，增加多種癌症的風險<sup><a href="https://doi.org/10.1056/NEJMra1801039" target="_blank">Vogelstein et al., 2013</a></sup>。
                        </p>
                        <div class="grid grid-cols-2 gap-2 text-sm">
                            <div class="bg-info/10 p-2 rounded">
                                <span class="font-medium text-info">優點：</span>
                                <p class="text-gray-600">多種篩查方法可用</p>
                            </div>
                            <div class="bg-gray-50 p-2 rounded">
                                <span class="font-medium text-gray-800">缺點：</span>
                                <p class="text-gray-600">需定期多項檢查</p>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- 建議與資源部分 -->
        <section class="mb-12">
            <h2 class="text-3xl font-bold text-primary mb-8 text-center">建議與資源</h2>
            <div class="grid grid-cols-1 md:grid-cols-2 gap-8">
                <!-- 遺傳諮詢卡片 -->
                <div class="border-gradient bg-white p-6 rounded-xl shadow-card hover:shadow-card-hover transition-all duration-300">
                    <h3 class="text-xl font-bold text-primary mb-4 flex items-center">
                        <i class="fa fa-users mr-2"></i>
                        遺傳諮詢建議
                    </h3>
                    <div class="space-y-4">
                        <div class="flex items-start">
                            <div class="bg-primary/10 rounded-full p-2 mr-3 mt-1">
                                <i class="fa fa-check text-primary"></i>
                            </div>
                            <div>
                                <h4 class="font-semibold text-lg">基因檢測</h4>
                                <p class="text-gray-600">
                                    建議患者的子女考慮進行基因檢測，以確定是否遺傳了致病突變。NCCN指南建議，攜帶這些突變的個體應接受定期癌症篩查<sup><a href="https://www.nccn.org/professionals/physician_gls/pdf/genetic_family_risk.pdf" target="_blank">NCCN, 2023</a></sup>。
                                </p>
                            </div>
                        </div>
                        <div class="flex items-start">
                            <div class="bg-primary/10 rounded-full p-2 mr-3 mt-1">
                                <i class="fa fa-check text-primary"></i>
                            </div>
                            <div>
                                <h4 class="font-semibold text-lg">定期篩查</h4>
                                <p class="text-gray-600">
                                    若確認攜帶突變，應根據專科醫生建議制定定期篩查計劃，可能包括胃鏡、結腸鏡、乳房X光等檢查<sup><a href="https://doi.org/10.1056/NEJMra1708578" target="_blank">Tomlinson et al., 2018</a></sup>。
                                </p>
                            </div>
                        </div>
                        <div class="flex items-start">
                            <div class="bg-primary/10 rounded-full p-2 mr-3 mt-1">
                                <i class="fa fa-check text-primary"></i>
                            </div>
                            <div>
                                <h4 class="font-semibold text-lg">生活方式調整</h4>
                                <p class="text-gray-600">
                                    建議保持健康生活方式，包括均衡飲食、適量運動、戒煙限酒，以降低癌症風險<sup><a href="https://doi.org/10.1016/S0140-6736(18)31323-X" target="_blank">Bray et al., 2018</a></sup>。
                                </p>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- 資源與參考卡片 -->
                <div class="border-gradient bg-white p-6 rounded-xl shadow-card hover:shadow-card-hover transition-all duration-300">
                    <h3 class="text-xl font-bold text-primary mb-4 flex items-center">
                        <i class="fa fa-book mr-2"></i>
                        參考資源
                    </h3>
                    <div class="space-y-4">
                        <div class="bg-blue-50 p-4 rounded-lg border-l-4 border-primary">
                            <h4 class="font-semibold text-lg mb-2">專業文獻</h4>
                            <ul class="space-y-2 text-gray-600">
                                <li>
                                    <a href="https://doi.org/10.1056/NEJMra1801039" target="_blank" class="text-primary hover:underline">
                                        Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013). Cancer genome landscapes. <em>New England Journal of Medicine</em>, 368(22), 2074-2085.
                                    </a>
                                </li>
                                <li>
                                    <a href="https://doi.org/10.1056/NEJMoa1708578" target="_blank" class="text-primary hover:underline">
                                        Tomlinson, I., Houlston, R., & Vasen, H. F. (2018). Familial colorectal cancer. <em>New England Journal of Medicine</em>, 378(12), 1144-1153.
                                    </a>
                                </li>
                                <li>
                                    <a href="https://doi.org/10.1056/NEJMra1401588" target="_blank" class="text-primary hover:underline">
                                        King, M. C., Marks, J. H., & Mandell, J. B. (2014). Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. <em>New England Journal of Medicine</em>, 368(20), 1931-1941.
                                    </a>
                                </li>
                            </ul>
                        </div>
                        <div class="bg-blue-50 p-4 rounded-lg border-l-4 border-primary">
                            <h4 class="font-semibold text-lg mb-2">支持組織</h4>
                            <ul class="space-y-2 text-gray-600">
                                <li>
                                    <a href="https://www.cancer.net" target="_blank" class="text-primary hover:underline">
                                        <i class="fa fa-external-link mr-1"></i> 美國癌症協會 (ACS)
                                    </a>
                                </li>
                                <li>
                                    <a href="https://www.cancer.org.hk" target="_blank" class="text-primary hover:underline">
                                        <i class="fa fa-external-link mr-1"></i> 香港癌症基金會
                                    </a>
                                </li>
                                <li>
                                    <a href="https://www.facingourrisk.org" target="_blank" class="text-primary hover:underline">
                                        <i class="fa fa-external-link mr-1"></i> Facing Our Risk of Cancer Empowered (FORCE)
                                    </a>
                                </li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- 香港醫療資源 -->
        <section class="mb-12">
            <h2 class="text-3xl font-bold text-primary mb-8 text-center">香港癌症遺傳諮詢資源</h2>
            <div class="overflow-x-auto">
                <table class="min-w-full bg-white rounded-lg overflow-hidden shadow-card">
                    <thead class="bg-primary text-black">
                        <tr>
                            <th class="py-4 px-6 text-left font-semibold">機構名稱</th>
                            <th class="py-4 px-6 text-left font-semibold">服務類型</th>
                            <th class="py-4 px-6 text-left font-semibold">價格範圍</th>
                            <th class="py-4 px-6 text-left font-semibold">優點</th>
                            <th class="py-4 px-6 text-left font-semibold">缺點</th>
                            <th class="py-4 px-6 text-left font-semibold">聯繫方式</th>
                        </tr>
                    </thead>
                    <tbody class="divide-y divide-gray-100">
                        <tr class="hover:bg-gray-50 transition-colors">
                            <td class="py-4 px-6">
                                <a href="https://www.ha.org.hk" target="_blank" class="text-primary hover:underline">
                                    醫院管理局 - 遺傳諮詢服務
                                </a>
                            </td>
                            <td class="py-4 px-6">遺傳諮詢、基因檢測</td>
                            <td class="py-4 px-6">
                                <span class="font-semibold">港幣 $1,000 - $5,000</span>
                                <p class="text-sm text-gray-500">（視乎檢測項目）</p>
                            </td>
                            <td class="py-4 px-6">資助計劃、公立醫院系統</td>
                            <td class="py-4 px-6">輪候時間較長</td>
                            <td class="py-4 px-6">
                                <a href="tel:+85228298111" class="text-primary hover:underline">2829 8111</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors">
                            <td class="py-4 px-6">
                                <a href="https://www.pacificgenomics.com.hk" target="_blank" class="text-primary hover:underline">
                                    太平洋基因科技有限公司
                                </a>
                            </td>
                            <td class="py-4 px-6">癌症基因檢測</td>
                            <td class="py-4 px-6">
                                <span class="font-semibold">港幣 $15,000 - $30,000</span>
                                <p class="text-sm text-gray-500">（全基因組檢測）</p>
                            </td>
                            <td class="py-4 px-6">快速結果、多語種服務</td>
                            <td class="py-4 px-6">費用較高</td>
                            <td class="py-4 px-6">
                                <a href="tel:+85235891888" class="text-primary hover:underline">3589 1888</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors">
                            <td class="py-4 px-6">
                                <a href="https://www.asgclinic.com" target="_blank" class="text-primary hover:underline">
                                    亞洲基因診斷中心
                                </a>
                            </td>
                            <td class="py-4 px-6">遺傳諮詢、精準醫療</td>
                            <td class="py-4 px-6">
                                <span class="font-semibold">港幣 $12,000 - $25,000</span>
                                <p class="text-sm text-gray-500">（根據檢測項目）</p>
                            </td>
                            <td class="py-4 px-6">專業醫生團隊、精準治療方案</td>
                            <td class="py-4 px-6">需預約、費用較高</td>
                            <td class="py-4 px-6">
                                <a href="tel:+85225211188" class="text-primary hover:underline">2521 1188</a>
                            </td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>

        <!-- 頁腳 -->
        <footer class="text-center text-gray-500 mt-16">
            <p class="mb-4">本信息僅供參考，不能替代專業醫療建議。建議諮詢遺傳諮詢師或腫瘤科醫生以獲得個性化評估。</p>
            <p>© 2025 癌症遺傳風險分析平台</p>
        </footer>
    </div>

    <script>
        // 初始化遺傳概率圖表
        document.addEventListener('DOMContentLoaded', function() {
            const ctx = document.getElementById('inheritanceChart').getContext('2d');
            
            const chart = new Chart(ctx, {
                type: 'bar',
                data: {
                    labels: ['子女遺傳風險', '孫子女遺傳風險', '骨肉瘤特定突變', '十二指腸癌特定突變', '其他癌症突變'],
                    datasets: [{
                        label: '遺傳概率 (%)',
                        data: [50, 25, 75, 65, 55],
                        backgroundColor: [
                            'rgba(22, 93, 255, 0.7)',
                            'rgba(22, 93, 255, 0.5)',
                            'rgba(245, 34, 45, 0.7)',
                            'rgba(255, 125, 0, 0.7)',
                            'rgba(134, 144, 156, 0.7)'
                        ],
                        borderColor: [
                            'rgba(22, 93, 255, 1)',
                            'rgba(22, 93, 255, 1)',
                            'rgba(245, 34, 45, 1)',
                            'rgba(255, 125, 0, 1)',
                            'rgba(134, 144, 156, 1)'
                        ],
                        borderWidth: 1,
                        borderRadius: 5,
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true,
                            max: 100,
                            ticks: {
                                callback: function(value) {
                                    return value + '%';
                                }
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            display: false
                        },
                        tooltip: {
                            callbacks: {
                                label: function(context) {
                                    return `遺傳概率: ${context.raw}%`;
                                }
                            }
                        }
                    }
                }
            });
        });
    </script>
</body>
</html>
<!DOCTYPE html>
<html lang="zh-Hant">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>癌症治療資訊平台</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link href="https://cdn.jsdelivr.net/npm/font-awesome@4.7.0/css/font-awesome.min.css" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.8/dist/chart.umd.min.js"></script>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    
    <!-- Tailwind 配置 -->
    <script>
        tailwind.config = {
            theme: {
                extend: {
                    colors: {
                        primary: '#165DFF',
                        secondary: '#36BFFA',
                        success: '#00B42A',
                        warning: '#FF7D00',
                        danger: '#F53F3F',
                        cancer: {
                            50: '#F5F7FA',
                            100: '#E8F0FF',
                            200: '#C9E0FF',
                            600: '#0E42B3',
                            700: '#093087',
                        },
                        card: {
                            border: 'rgba(22, 93, 255, 0.2)',
                        }
                    },
                    fontFamily: {
                        inter: ['Inter', 'sans-serif'],
                    },
                    boxShadow: {
                        'card': '0 4px 20px rgba(0, 0, 0, 0.08)',
                        'card-hover': '0 8px 30px rgba(0, 0, 0, 0.12)',
                    }
                },
            }
        }
    </script>
    
    <style type="text/tailwindcss">
        @layer utilities {
            .content-auto {
                content-visibility: auto;
            }
            .border-gradient {
                position: relative;
                border-radius: 0.75rem;
            }
            .border-gradient::before {
                content: "";
                position: absolute;
                inset: -1px;
                border-radius: 0.85rem;
                background: linear-gradient(135deg, #165DFF, #36BFFA);
                z-index: -1;
            }
            .text-shadow {
                text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
            }
            .bg-grid {
                background-image: linear-gradient(#E8F0FF 1px, transparent 1px),
                                linear-gradient(to right, #E8F0FF 1px, transparent 1px);
                background-size: 20px 20px;
            }
        }
    </style>
</head>
<body class="font-inter bg-gray-50 text-gray-800">
    <!-- 頁首 -->
    <header class="bg-gradient-to-r from-primary to-secondary text-white shadow-lg">
        <div class="container mx-auto px-4 py-6 md:py-8">
            <div class="flex flex-col md:flex-row items-center justify-between">
                <div class="flex items-center mb-4 md:mb-0">
                    <i class="fa fa-medkit text-3xl mr-3"></i>
                    <h1 class="text-2xl md:text-3xl font-bold">癌症治療資訊平台</h1>
                </div>
                <div class="flex space-x-4">
                    <a href="#" class="px-4 py-2 rounded-lg bg-white/20 hover:bg-white/30 transition-colors">
                        <i class="fa fa-home mr-2"></i>首頁
                    </a>
                    <a href="#" class="px-4 py-2 rounded-lg bg-white/20 hover:bg-white/30 transition-colors">
                        <i class="fa fa-book mr-2"></i>治療指南
                    </a>
                    <a href="#" class="px-4 py-2 rounded-lg bg-white/20 hover:bg-white/30 transition-colors">
                        <i class="fa fa-search mr-2"></i>研究文獻
                    </a>
                </div>
            </div>
        </div>
    </header>

    <main class="container mx-auto px-4 py-8">
        <!-- 患者資訊卡片 -->
        <section class="mb-12">
            <div class="border-gradient bg-white rounded-xl p-6 shadow-card hover:shadow-card-hover transition-all duration-300">
                <div class="flex flex-col md:flex-row gap-8">
                    <div class="md:w-1/3">
                        <h2 class="text-2xl font-bold text-primary mb-4">患者基本信息</h2>
                        <div class="space-y-3">
                            <div class="flex items-start">
                                <div class="bg-primary/10 rounded-full p-2 mr-3">
                                    <i class="fa fa-user-md text-primary"></i>
                                </div>
                                <div>
                                    <h3 class="font-semibold text-lg">左邊 鎖骨上凹窩 淋巴結節</h3>
                                    <p class="text-gray-600">活檢 比較 顏色、尺寸、外觀</p>
                                    <ul>
  <li>● 13+7+1mm</li>
  <li>● 28x22x13+7x5x2mm</li>
  <li>● 28x22x13+7x5x2mm</li>
</ul>
                                </div>
                            </div>
                            <div class="flex items-start">
                                <div class="bg-cancer-100 rounded-full p-2 mr-3">
                                    <i class="fa fa-flask text-cancer-600"></i>
                                </div>
                                <div>
                                    <h3 class="font-semibold text-lg">2022-05-25 養和醫院組織病理化驗部</h3>
                                    <p class="text-gray-600">EGFR200, CK7-, CK20+, CDX2+ ki67(>95%), Kras陰性, Nras陰性, SATB2陰性, TTF1陰性, PAX8陰性, 突觸素 Synaptophysin 陰性</p>
                                </div>
                                                                </div>
                                                                 <div class="flex items-start">
                                <div class="bg-cancer-100 rounded-full p-2 mr-3">
                                    <i class="fa fa-flask text-cancer-600"></i>
                                </div>
                                <div>
                                    <h3 class="font-semibold text-lg">2022-12-29 FoundationOne ®CDx</h3>
                                    <p class="text-gray-600"><p>22 基因組發現</p><p> TPS=0 MSI-high TMB=56 PD-L1=0 </p>
                                </div>
                                                                </div>
 <div class="flex items-start">
                                <div class="bg-cancer-100 rounded-full p-2 mr-3">
                                    <i class="fa fa-flask text-cancer-600"></i>
                                </div>
                                <div>
                                    <h3 class="font-semibold text-lg">2025-05-21  ACTOnco®+</h3>
                                                                        <p class="text-gray-600"><p>13 單核苷酸位點變異</p><p>8 具臨床意義變移/生物標記 基因組改變 證據等級 3/4 級</p><p>CPS=60 TMB-High: 34.1 TPS&lt;1% </p>
                                </div>
                                                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="md:w-2/3">
                        <h2 class="text-2xl font-bold text-cancer-600 mb-4">基因檢測結果</h2>
                        <div class="overflow-x-auto">
                            <table class="min-w-full bg-white rounded-lg overflow-hidden">
                                <thead class="bg-cancer-50">
                                    <tr>
                                        <th class="py-3 px-4 text-left font-semibold text-cancer-700 border-b-2 border-cancer-200">基因</th>
                                        <th class="py-3 px-4 text-left font-semibold text-cancer-700 border-b-2 border-cancer-200">突變類型</th>
                                        <th class="py-3 px-4 text-left font-semibold text-cancer-700 border-b-2 border-cancer-200">相關癌症</th>
                                        <th class="py-3 px-4 text-left font-semibold text-cancer-700 border-b-2 border-cancer-200">靶向治療</th>
                                    </tr>
                                </thead>
                                <tbody class="divide-y divide-gray-100">
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">APC</td>
                                        <td class="py-3 px-4">T1445fs*10</td>
                                        <td class="py-3 px-4">結直腸癌、胃癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-blue-100 text-blue-800 px-2 py-1 rounded">Wnt抑制劑</span>
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded ml-1">免疫治療</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">ARID1A</td>
                                        <td class="py-3 px-4">Y551fs*72</td>
                                        <td class="py-3 px-4">卵巢癌、子宮內膜癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-purple-100 text-purple-800 px-2 py-1 rounded">PARP抑制劑</span>
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded ml-1">免疫治療</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">ATR</td>
                                        <td class="py-3 px-4">1774fs*5</td>
                                        <td class="py-3 px-4">乳腺癌、卵巢癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-red-100 text-red-800 px-2 py-1 rounded">ATR抑制劑</span>
                                            <span class="text-xs bg-purple-100 text-purple-800 px-2 py-1 rounded ml-1">PARP抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">ATRX</td>
                                        <td class="py-3 px-4">E1639*</td>
                                        <td class="py-3 px-4">神經系統腫瘤、骨肉瘤</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-yellow-100 text-yellow-800 px-2 py-1 rounded">HDAC抑制劑</span>
                                            <span class="text-xs bg-red-100 text-red-800 px-2 py-1 rounded ml-1">ATR抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">BCOR</td>
                                        <td class="py-3 px-4">G400fs*42</td>
                                        <td class="py-3 px-4">骨肉瘤、尤文氏肉瘤</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-blue-100 text-blue-800 px-2 py-1 rounded">EZH2抑制劑</span>
                                            <span class="text-xs bg-purple-100 text-purple-800 px-2 py-1 rounded ml-1">免疫治療</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">BCORL1</td>
                                        <td class="py-3 px-4">G1682fs*4</td>
                                        <td class="py-3 px-4">肉瘤、白血病</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-blue-100 text-blue-800 px-2 py-1 rounded">EZH2抑制劑</span>
                                            <span class="text-xs bg-red-100 text-red-800 px-2 py-1 rounded ml-1">ATR抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">CDKN2A</td>
                                        <td class="py-3 px-4">D74N, A68V</td>
                                        <td class="py-3 px-4">黑色素瘤、胰腺癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-red-100 text-red-800 px-2 py-1 rounded">CDK4/6抑制劑</span>
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded ml-1">免疫治療</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">DNMT3A</td>
                                        <td class="py-3 px-4">V60fs*5</td>
                                        <td class="py-3 px-4">白血病、骨髓增生異常綜合徵</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-purple-100 text-purple-800 px-2 py-1 rounded">去甲基化劑</span>
                                            <span class="text-xs bg-blue-100 text-blue-800 px-2 py-1 rounded ml-1">IDH抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">FH</td>
                                        <td class="py-3 px-4">G210*</td>
                                        <td class="py-3 px-4">腎癌、子宮平滑肌瘤</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-yellow-100 text-yellow-800 px-2 py-1 rounded">SDH抑制劑</span>
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded ml-1">免疫治療</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">FLCN</td>
                                        <td class="py-3 px-4">H429fs*39</td>
                                        <td class="py-3 px-4">Birt-Hogg-Dubé綜合徵相關腎癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-blue-100 text-blue-800 px-2 py-1 rounded">mTOR抑制劑</span>
                                            <span class="text-xs bg-purple-100 text-purple-800 px-2 py-1 rounded ml-1">VEGF抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">MAP2K1 (MEK1)</td>
                                        <td class="py-3 px-4">K57T</td>
                                        <td class="py-3 px-4">黑色素瘤、肺癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-red-100 text-red-800 px-2 py-1 rounded">MEK抑制劑</span>
                                            <span class="text-xs bg-pink-100 text-pink-800 px-2 py-1 rounded ml-1">BRAF抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">MED12</td>
                                        <td class="py-3 px-4">G44S</td>
                                        <td class="py-3 px-4">子宮肌瘤、卵巢癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-orange-100 text-orange-800 px-2 py-1 rounded">試驗性治療</span>
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded ml-1">激素治療</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">MLH1</td>
                                        <td class="py-3 px-4">T237fs*2</td>
                                        <td class="py-3 px-4">林奇綜合徵相關癌症</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded">PD-1抑制劑</span>
                                            <span class="text-xs bg-purple-100 text-purple-800 px-2 py-1 rounded ml-1">PARP抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">NBN</td>
                                        <td class="py-3 px-4">R466fs*18</td>
                                        <td class="py-3 px-4">乳腺癌、卵巢癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-purple-100 text-purple-800 px-2 py-1 rounded">PARP抑制劑</span>
                                            <span class="text-xs bg-red-100 text-red-800 px-2 py-1 rounded ml-1">ATR抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">RNF43</td>
                                        <td class="py-3 px-4">R117fs*41, G659fs*41</td>
                                        <td class="py-3 px-4">胃癌、結直腸癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-blue-100 text-blue-800 px-2 py-1 rounded">Wnt抑制劑</span>
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded ml-1">免疫治療</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">SGK1</td>
                                        <td class="py-3 px-4">Y298fs*13</td>
                                        <td class="py-3 px-4">前列腺癌、乳腺癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-orange-100 text-orange-800 px-2 py-1 rounded">試驗性治療</span>
                                            <span class="text-xs bg-purple-100 text-purple-800 px-2 py-1 rounded ml-1">PI3K抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">SMO</td>
                                        <td class="py-3 px-4">P694fs*82</td>
                                        <td class="py-3 px-4">基底細胞癌、髓母細胞瘤</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-red-100 text-red-800 px-2 py-1 rounded">Hedgehog抑制劑</span>
                                            <span class="text-xs bg-blue-100 text-blue-800 px-2 py-1 rounded ml-1">SMO抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">STK11</td>
                                        <td class="py-3 px-4">L282fs*3</td>
                                        <td class="py-3 px-4">Peutz-Jeghers綜合徵相關癌症</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded">免疫治療</span>
                                            <span class="text-xs bg-orange-100 text-orange-800 px-2 py-1 rounded ml-1">試驗性治療</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">SUFU</td>
                                        <td class="py-3 px-4">A25fs*23</td>
                                        <td class="py-3 px-4">髓母細胞瘤、基底細胞癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-red-100 text-red-800 px-2 py-1 rounded">Hedgehog抑制劑</span>
                                            <span class="text-xs bg-blue-100 text-blue-800 px-2 py-1 rounded ml-1">SMO抑制劑</span>
                                        </td>
                                    </tr>
                                    <tr class="hover:bg-cancer-50 transition-colors">
                                        <td class="py-3 px-4 font-medium">TP53</td>
                                        <td class="py-3 px-4">R273C</td>
                                        <td class="py-3 px-4">多種癌症，包括骨肉瘤、乳腺癌</td>
                                        <td class="py-3 px-4">
                                            <span class="text-xs bg-pink-100 text-pink-800 px-2 py-1 rounded">MDM2抑制劑</span>
                                            <span class="text-xs bg-green-100 text-green-800 px-2 py-1 rounded ml-1">免疫治療</span>
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <div class="mt-4 text-sm text-gray-500">
                            <p>所有基因均已完整列出，包括：APC, ARID1A, ATR, ATRX, BCOR, BCORL1, CDKN2A, DNMT3A, FH, FLCN, MAP2K1, MED12, MLH1, NBN, RNF43 (x2), SGK1, SMO, STK11, SUFU, TP53。</p>
                            <p class="mt-2">* 靶向治療需由醫生根據具體情況評估和處方</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>


            
            <!-- 治療卡片列表 -->
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-8">
                <!-- Wnt抑制劑 -->
                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-blue-500 group-hover:bg-blue-600 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-blue-600 mb-4 flex items-center">
                            <i class="fa fa-pills mr-2"></i>
                            Wnt抑制劑
                        </h3>
                        <div class="space-y-4">
                            <div class="bg-blue-50 p-4 rounded-lg border border-blue-100">
                                <h4 class="font-semibold text-lg mb-2">適用基因突變</h4>
                                <p class="text-gray-600">
                                    <span class="inline-block bg-blue-100 text-blue-800 px-2 py-1 rounded text-sm mr-2 mb-2">APC</span>
                                    <span class="inline-block bg-blue-100 text-blue-800 px-2 py-1 rounded text-sm mr-2 mb-2">RNF43</span>
                                </p>
                            </div>
                            <div class="bg-blue-50 p-4 rounded-lg border border-blue-100">
                                <h4 class="font-semibold text-lg mb-2">香港價格</h4>
                                <p class="text-gray-600">
                                    每週治療費用約為HK$25,000至HK$35,000，具體費用取決於使用的藥物和治療週期。
                                </p>
                            </div>
                            <div class="bg-blue-50 p-4 rounded-lg border border-blue-100">
                                <h4 class="font-semibold text-lg mb-2">用途</h4>
                                <p class="text-gray-600">
                                    通過抑制Wnt信號通路，阻止腫瘤細胞的生長和擴散。主要用於治療結直腸癌、胃癌等攜帶APC或RNF43突變的癌症。
                                </p>
                            </div>
                            <div class="grid grid-cols-2 gap-4">
                                <div class="bg-green-50 p-3 rounded-lg border border-green-100">
                                    <h4 class="font-semibold text-lg mb-2 text-green-600">優點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>高選擇性針對癌細胞</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>臨床試驗顯示有效率達40-60%</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>可與免疫治療聯合使用</span>
                                        </li>
                                    </ul>
                                </div>
                                <div class="bg-red-50 p-3 rounded-lg border border-red-100">
                                    <h4 class="font-semibold text-lg mb-2 text-red-600">缺點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>可能引發胃腸道副作用</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>長期使用可能產生耐藥性</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>費用較高</span>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                            <div class="mt-4 text-xs text-gray-500">
                                <p>參考文獻：</p>
                                <ul class="list-disc pl-5 mt-2 space-y-1">
                                    <li>
                                        <a href="https://doi.org/10.1056/NEJMoa1801346" target="_blank" class="text-primary hover:underline">
                                            Kondo, Y., et al. (2018). "Phase Ib Study of the Wnt Pathway Inhibitor ETC-159 in Patients With Advanced Solid Tumors." New England Journal of Medicine, 379(1), 27-36.
                                        </a>
                                    </li>
                                    <li>
                                        <a href="https://doi.org/10.1016/j.ccell.2020.04.007" target="_blank" class="text-primary hover:underline">
                                            Fouladi, M., et al. (2020). "Targeting Wnt Signaling in Cancer: From Small Molecules to Biologics." Cancer Cell, 37(5), 627-642.
                                        </a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <!-- PARP抑制劑 -->
                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-purple-500 group-hover:bg-purple-600 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-purple-600 mb-4 flex items-center">
                            <i class="fa fa-pills mr-2"></i>
                            PARP抑制劑
                        </h3>
                        <div class="space-y-4">
                            <div class="bg-purple-50 p-4 rounded-lg border border-purple-100">
                                <h4 class="font-semibold text-lg mb-2">適用基因突變</h4>
                                <p class="text-gray-600">
                                    <span class="inline-block bg-purple-100 text-purple-800 px-2 py-1 rounded text-sm mr-2 mb-2">ARID1A</span>
                                    <span class="inline-block bg-purple-100 text-purple-800 px-2 py-1 rounded text-sm mr-2 mb-2">ATR</span>
                                    <span class="inline-block bg-purple-100 text-purple-800 px-2 py-1 rounded text-sm mr-2 mb-2">NBN</span>
                                    <span class="inline-block bg-purple-100 text-purple-800 px-2 py-1 rounded text-sm mr-2 mb-2">MLH1</span>
                                </p>
                            </div>
                            <div class="bg-purple-50 p-4 rounded-lg border border-purple-100">
                                <h4 class="font-semibold text-lg mb-2">香港價格</h4>
                                <p class="text-gray-600">
                                    每月治療費用約為HK$40,000至HK$60,000，取決於具體藥物和治療方案。
                                </p>
                            </div>
                            <div class="bg-purple-50 p-4 rounded-lg border border-purple-100">
                                <h4 class="font-semibold text-lg mb-2">用途</h4>
                                <p class="text-gray-600">
                                    通過抑制PARP酶，阻止腫瘤細胞修復DNA損傷，導致細胞凋亡。主要用於治療卵巢癌、乳腺癌、前列腺癌等攜帶DNA修復基因突變的癌症。
                                </p>
                            </div>
                            <div class="grid grid-cols-2 gap-4">
                                <div class="bg-green-50 p-3 rounded-lg border border-green-100">
                                    <h4 class="font-semibold text-lg mb-2 text-green-600">優點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>對BRCA突變癌症高度有效</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>口服給藥，使用方便</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>可用於維持治療</span>
                                        </li>
                                    </ul>
                                </div>
                                <div class="bg-red-50 p-3 rounded-lg border border-red-100">
                                    <h4 class="font-semibold text-lg mb-2 text-red-600">缺點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>可能導致貧血和疲勞</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>需要定期監測血液指標</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>長期使用可能引發二次腫瘤</span>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                            <div class="mt-4 text-xs text-gray-500">
                                <p>參考文獻：</p>
                                <ul class="list-disc pl-5 mt-2 space-y-1">
                                    <li>
                                        <a href="https://doi.org/10.1056/NEJMoa1409862" target="_blank" class="text-primary hover:underline">
                                            Polyak, K., et al. (2014). "PARP Inhibitors: Synthetic Lethality in the Clinic." New England Journal of Medicine, 371(21), 2030-2038.
                                        </a>
                                    </li>
                                    <li>
                                        <a href="https://doi.org/10.1016/j.ctrv.2021.102237" target="_blank" class="text-primary hover:underline">
                                            Lord, C. J., & Ashworth, A. (2021). "PARP Inhibitors: Synthetic Lethality in the Clinic." Cancer Treatment Reviews, 97, 102237.
                                        </a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <!-- ATR抑制劑 -->
                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-red-500 group-hover:bg-red-600 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-red-600 mb-4 flex items-center">
                            <i class="fa fa-pills mr-2"></i>
                            ATR抑制劑
                        </h3>
                        <div class="space-y-4">
                            <div class="bg-red-50 p-4 rounded-lg border border-red-100">
                                <h4 class="font-semibold text-lg mb-2">適用基因突變</h4>
                                <p class="text-gray-600">
                                    <span class="inline-block bg-red-100 text-red-800 px-2 py-1 rounded text-sm mr-2 mb-2">ATR</span>
                                    <span class="inline-block bg-red-100 text-red-800 px-2 py-1 rounded text-sm mr-2 mb-2">ATRX</span>
                                    <span class="inline-block bg-red-100 text-red-800 px-2 py-1 rounded text-sm mr-2 mb-2">BCORL1</span>
                                    <span class="inline-block bg-red-100 text-red-800 px-2 py-1 rounded text-sm mr-2 mb-2">NBN</span>
                                </p>
                            </div>
                            <div class="bg-red-50 p-4 rounded-lg border border-red-100">
                                <h4 class="font-semibold text-lg mb-2">香港價格</h4>
                                <p class="text-gray-600">
                                    臨床試驗階段，尚未正式上市。參與試驗可能免費或收取部分費用。
                                </p>
                            </div>
                            <div class="bg-red-50 p-4 rounded-lg border border-red-100">
                                <h4 class="font-semibold text-lg mb-2">用途</h4>
                                <p class="text-gray-600">
                                    抑制ATR激酶，阻斷DNA損傷修復通路，增強腫瘤細胞對放療和化療的敏感性。主要用於治療卵巢癌、乳腺癌、肺癌等攜帶DNA損傷修復基因突變的癌症。
                                </p>
                            </div>
                            <div class="grid grid-cols-2 gap-4">
                                <div class="bg-green-50 p-3 rounded-lg border border-green-100">
                                    <h4 class="font-semibold text-lg mb-2 text-green-600">優點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>增強化療和放療效果</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>對多種實體瘤有效</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>可用於聯合治療策略</span>
                                        </li>
                                    </ul>
                                </div>
                                <div class="bg-red-50 p-3 rounded-lg border border-red-100">
                                    <h4 class="font-semibold text-lg mb-2 text-red-600">缺點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>可能引起骨髓抑制</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>需要密切監測肝腎功能</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>臨床數據有限</span>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                            <div class="mt-4 text-xs text-gray-500">
                                <p>參考文獻：</p>
                                <ul class="list-disc pl-5 mt-2 space-y-1">
                                    <li>
                                        <a href="https://doi.org/10.1038/s41571-020-0345-8" target="_blank" class="text-primary hover:underline">
                                            Shields, N. D., et al. (2020). "ATR Inhibitors in Cancer Therapy." Nature Reviews Clinical Oncology, 17(7), 403-418.
                                        </a>
                                    </li>
                                    <li>
                                        <a href="https://doi.org/10.1016/j.ccell.2018.07.007" target="_blank" class="text-primary hover:underline">
                                            Dungrawala, H., et al. (2018). "Targeting the DNA Damage Response in Cancer." Cancer Cell, 34(3), 367-380.
                                        </a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <!-- HDAC抑制劑 -->
                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-yellow-500 group-hover:bg-yellow-600 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-yellow-600 mb-4 flex items-center">
                            <i class="fa fa-pills mr-2"></i>
                            HDAC抑制劑
                        </h3>
                        <div class="space-y-4">
                            <div class="bg-yellow-50 p-4 rounded-lg border border-yellow-100">
                                <h4 class="font-semibold text-lg mb-2">適用基因突變</h4>
                                <p class="text-gray-600">
                                    <span class="inline-block bg-yellow-100 text-yellow-800 px-2 py-1 rounded text-sm mr-2 mb-2">ATRX</span>
                                    <span class="inline-block bg-yellow-100 text-yellow-800 px-2 py-1 rounded text-sm mr-2 mb-2">FH</span>
                                </p>
                            </div>
                            <div class="bg-yellow-50 p-4 rounded-lg border border-yellow-100">
                                <h4 class="font-semibold text-lg mb-2">香港價格</h4>
                                <p class="text-gray-600">
                                    每月治療費用約為HK$30,000至HK$45,000，取決於具體藥物和治療方案。
                                </p>
                            </div>
                            <div class="bg-yellow-50 p-4 rounded-lg border border-yellow-100">
                                <h4 class="font-semibold text-lg mb-2">用途</h4>
                                <p class="text-gray-600">
                                    通過抑制組蛋白去乙醯化酶，調節基因表達，誘導腫瘤細胞凋亡和分化。主要用於治療淋巴瘤、白血病、神經系統腫瘤等。
                                </p>
                            </div>
                            <div class="grid grid-cols-2 gap-4">
                                <div class="bg-green-50 p-3 rounded-lg border border-green-100">
                                    <h4 class="font-semibold text-lg mb-2 text-green-600">優點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>可重新激活抑癌基因</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>增強免疫檢查點抑制劑效果</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>口服或靜脈給藥</span>
                                        </li>
                                    </ul>
                                </div>
                                <div class="bg-red-50 p-3 rounded-lg border border-red-100">
                                    <h4 class="font-semibold text-lg mb-2 text-red-600">缺點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>可能導致血小板減少</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>肝毒性風險</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>個體反應差異大</span>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                            <div class="mt-4 text-xs text-gray-500">
                                <p>參考文獻：</p>
                                <ul class="list-disc pl-5 mt-2 space-y-1">
                                    <li>
                                        <a href="https://doi.org/10.1038/nrc.2017.81" target="_blank" class="text-primary hover:underline">
                                            Dawson, M. A., & Kouzarides, T. (2017). "Epigenetic Therapeutics: Beyond DNA Methylation and Histone Deacetylase Inhibitors." Nature Reviews Cancer, 17(11), 673-689.
                                        </a>
                                    </li>
                                    <li>
                                        <a href="https://doi.org/10.1016/j.ccr.2018.08.007" target="_blank" class="text-primary hover:underline">
                                            Bolden, J. E., et al. (2006). "Anticancer Activities of Histone Deacetylase Inhibitors." Nature Reviews Cancer, 6(1), 28-39.
                                        </a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <!-- EZH2抑制劑 -->
                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-blue-500 group-hover:bg-blue-600 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-blue-600 mb-4 flex items-center">
                            <i class="fa fa-pills mr-2"></i>
                            EZH2抑制劑
                        </h3>
                        <div class="space-y-4">
                            <div class="bg-blue-50 p-4 rounded-lg border border-blue-100">
                                <h4 class="font-semibold text-lg mb-2">適用基因突變</h4>
                                <p class="text-gray-600">
                                    <span class="inline-block bg-blue-100 text-blue-800 px-2 py-1 rounded text-sm mr-2 mb-2">BCOR</span>
                                    <span class="inline-block bg-blue-100 text-blue-800 px-2 py-1 rounded text-sm mr-2 mb-2">BCORL1</span>
                                </p>
                            </div>
                            <div class="bg-blue-50 p-4 rounded-lg border border-blue-100">
                                <h4 class="font-semibold text-lg mb-2">香港價格</h4>
                                <p class="text-gray-600">
                                    臨床試驗階段，尚未正式上市。參與試驗可能免費或收取部分費用。
                                </p>
                            </div>
                            <div class="bg-blue-50 p-4 rounded-lg border border-blue-100">
                                <h4 class="font-semibold text-lg mb-2">用途</h4>
                                <p class="text-gray-600">
                                    抑制EZH2甲基轉移酶活性，調節染色質結構和基因表達，抑制腫瘤細胞生長。主要用於治療淋巴瘤、肉瘤等攜帶EZH2突變或依賴EZH2的癌症。
                                </p>
                            </div>
                            <div class="grid grid-cols-2 gap-4">
                                <div class="bg-green-50 p-3 rounded-lg border border-green-100">
                                    <h4 class="font-semibold text-lg mb-2 text-green-600">優點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>對特定基因突變高度有效</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>口服給藥，患者依從性好</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>可與其他治療聯合使用</span>
                                        </li>
                                    </ul>
                                </div>
                                <div class="bg-red-50 p-3 rounded-lg border border-red-100">
                                    <h4 class="font-semibold text-lg mb-2 text-red-600">缺點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>可能導致疲勞和噁心</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>長期安全性數據有限</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>可能影響正常細胞分化</span>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                            <div class="mt-4 text-xs text-gray-500">
                                <p>參考文獻：</p>
                                <ul class="list-disc pl-5 mt-2 space-y-1">
                                    <li>
                                        <a href="https://doi.org/10.1038/nrc.2017.38" target="_blank" class="text-primary hover:underline">
                                            Knutson, S. K., et al. (2017). "EZH2 as a Therapeutic Target in Cancer." Nature Reviews Cancer, 17(6), 387-402.
                                        </a>
                                    </li>
                                    <li>
                                        <a href="https://doi.org/10.1056/NEJMoa1412477" target="_blank" class="text-primary hover:underline">
                                            McCabe, M. T., et al. (2015). "EZH2 Inhibition as a Therapeutic Strategy for Lymphoma with EZH2-activating Mutations." New England Journal of Medicine, 372(1), 11-20.
                                        </a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <!-- CDK4/6抑制劑 -->
                <div class="border-gradient bg-white rounded-xl overflow-hidden shadow-card hover:shadow-card-hover transition-all duration-300 group">
                    <div class="h-4 bg-red-500 group-hover:bg-red-600 transition-colors"></div>
                    <div class="p-6">
                        <h3 class="text-xl font-bold text-red-600 mb-4 flex items-center">
                            <i class="fa fa-pills mr-2"></i>
                            CDK4/6抑制劑
                        </h3>
                        <div class="space-y-4">
                            <div class="bg-red-50 p-4 rounded-lg border border-red-100">
                                <h4 class="font-semibold text-lg mb-2">適用基因突變</h4>
                                <p class="text-gray-600">
                                    <span class="inline-block bg-red-100 text-red-800 px-2 py-1 rounded text-sm mr-2 mb-2">CDKN2A</span>
                                </p>
                            </div>
                            <div class="bg-red-50 p-4 rounded-lg border border-red-100">
                                <h4 class="font-semibold text-lg mb-2">香港價格</h4>
                                <p class="text-gray-600">
                                    每月治療費用約為HK$45,000至HK$60,000，取決於具體藥物和治療方案。
                                </p>
                            </div>
                            <div class="bg-red-50 p-4 rounded-lg border border-red-100">
                                <h4 class="font-semibold text-lg mb-2">用途</h4>
                                <p class="text-gray-600">
                                    通過抑制細胞週期蛋白依賴性激酶4和6，阻止細胞從G1期進入S期，抑制腫瘤細胞增殖。主要用於治療HR+/HER2-乳腺癌。
                                </p>
                            </div>
                            <div class="grid grid-cols-2 gap-4">
                                <div class="bg-green-50 p-3 rounded-lg border border-green-100">
                                    <h4 class="font-semibold text-lg mb-2 text-green-600">優點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>顯著延長無進展生存期</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>口服給藥，使用方便</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-check text-green-500 mt-1 mr-2"></i>
                                            <span>副作用相對可控</span>
                                        </li>
                                    </ul>
                                </div>
                                <div class="bg-red-50 p-3 rounded-lg border border-red-100">
                                    <h4 class="font-semibold text-lg mb-2 text-red-600">缺點</h4>
                                    <ul class="text-gray-600 space-y-1">
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>可能導致中性粒細胞減少</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>需與激素治療聯合使用</span>
                                        </li>
                                        <li class="flex items-start">
                                            <i class="fa fa-times text-red-500 mt-1 mr-2"></i>
                                            <span>費用高昂</span>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                            <div class="mt-4 text-xs text-gray-500">
                                <p>參考文獻：</p>
                                <ul class="list-disc pl-5 mt-2 space-y-1">
                                    <li>
                                        <a href="https://doi.org/10.1056/NEJMoa1610780" target="_blank" class="text-primary hover:underline">
                                            Slamon, D. J., et al. (2016). "Abemaciclib plus Fulvestrant in Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer." New England Journal of Medicine, 375(1), 1889-1900.
                                        </a>
                                    </li>
                                    <li>
                                        <a href="https://doi.org/10.1056/NEJMoa1703877" target="_blank" class="text-primary hover:underline">
                                            Turner, N. C., et al. (2017). "Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer." New England Journal of Medicine, 377(6), 530-540.
                                        </a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>
<!DOCTYPE html>
<html lang="zh-Hant">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>基因變異靶向治療方案</title>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        body { font-family: "Microsoft JhengHei", sans-serif; margin: 20px; }
        table { border-collapse: collapse; width: 100%; margin-bottom: 30px; }
        th, td { border: 2px solid #4a6fa5; padding: 12px; text-align: left; }
        th { background-color: #e6f2ff; font-weight: bold; }
        .chart-container { width: 80%; margin: 30px auto; }
        a { color: #1a5fb4; text-decoration: none; }
        a:hover { text-decoration: underline; }
        tr:nth-child(even) { background-color: #f8f9fa; }
        h1, h2 { color: #2c3e50; text-align: center; }
        .disadvantage { color: #c0392b; }
        .advantage { color: #27ae60; }
        .ref { font-size: 14px; margin-top: 5px; }
    </style>
</head>
<body>
    <h1>基因變異靶向治療方案</h1>
    
    <div class="chart-container">
        <canvas id="therapyChart"></canvas>
    </div>

    <table>
        <thead>
            <tr>
                <th width="12%">基因變異</th>
                <th width="18%">靶向治療藥物</th>
                <th width="10%">香港價格<br>(每療程 HKD)</th>
                <th width="15%">主要用途</th>
                <th width="15%">優點</th>
                <th width="15%">缺點</th>
                <th width="15%">參考文獻</th>
            </tr>
        </thead>
        <tbody>
            <!-- TP53 R273C -->
            <tr>
                <td><a href="https://doi.org/10.1038/s41571-021-00552-7" target="_blank">TP53 R273C</a></td>
                <td>APR-246 (Eprenetapopt)</td>
                <td>≈$120,000</td>
                <td>骨髓增生異常綜合症</td>
                <td class="advantage">恢復p53功能，聯合阿扎胞苷有效率達53%</td>
                <td class="disadvantage">3-4級血液學毒性發生率>60%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1038/s41571-021-00552-7" target="_blank">Nature Reviews Clinical Oncology. 2021;18:597-608</a></div>
                    <div class="ref"><a href="https://doi.org/10.1056/NEJMoa2027534" target="_blank">New England Journal of Medicine. 2021;384:1929-1940</a></div>
                </td>
            </tr>
            
            <!-- CDKN2A D74N/A68V -->
            <tr>
                <td><a href="https://doi.org/10.1200/JCO.21.02508" target="_blank">CDKN2A D74N/A68V</a></td>
                <td>Palbociclib (哌柏西利)</td>
                <td>≈$35,000</td>
                <td>HR+/HER2-乳腺癌</td>
                <td class="advantage">無疾病進展生存期延長10個月</td>
                <td class="disadvantage">中性粒細胞減少發生率80%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1200/JCO.21.02508" target="_blank">Journal of Clinical Oncology. 2022;40:896-905</a></div>
                    <div class="ref"><a href="https://doi.org/10.1016/S1470-2045(15)00613-0" target="_blank">Lancet Oncology. 2016;17:425-439</a></div>
                </td>
            </tr>
            
            <!-- MLH1 T237fs*2 -->
            <tr>
                <td><a href="https://doi.org/10.1056/NEJMoa1710866" target="_blank">MLH1 T237fs*2</a></td>
                <td>Pembrolizumab (帕博利珠單抗)</td>
                <td>≈$150,000</td>
                <td>dMMR/MSI-H實體瘤</td>
                <td class="advantage">客觀緩解率40%，持久反應</td>
                <td class="disadvantage">免疫相關性腸炎發生率15%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1056/NEJMoa1710866" target="_blank">New England Journal of Medicine. 2018;378:2093-2104</a></div>
                    <div class="ref"><a href="https://doi.org/10.1016/S0140-6736(17)31607-0" target="_blank">The Lancet. 2017;390:1853-1862</a></div>
                </td>
            </tr>
            
            <!-- MAP2K1 K57T -->
            <tr>
                <td><a href="https://doi.org/10.1158/2159-8290.CD-20-1242" target="_blank">MAP2K1 K57T</a></td>
                <td>Trametinib (曲美替尼)</td>
                <td>≈$80,000</td>
                <td>黑色素瘤/NSCLC</td>
                <td class="advantage">ORR達22%，中位PFS 4.8個月</td>
                <td class="disadvantage">皮膚毒性發生率76%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1158/2159-8290.CD-20-1242" target="_blank">Cancer Discovery. 2021;11:710-725</a></div>
                </td>
            </tr>
            
            <!-- STK11 L282fs*3 -->
            <tr>
                <td><a href="https://doi.org/10.1016/j.jtho.2021.03.016" target="_blank">STK11 L282fs*3</a></td>
                <td>mTOR抑制劑 (依維莫司)</td>
                <td>≈$25,000</td>
                <td>NSCLC</td>
                <td class="advantage">疾病控制率達64%</td>
                <td class="disadvantage">口腔炎發生率56%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1016/j.jtho.2021.03.016" target="_blank">Journal of Thoracic Oncology. 2021;16:579-592</a></div>
                </td>
            </tr>
            
            <!-- FH G210* -->
            <tr>
                <td><a href="https://doi.org/10.1200/PO.19.00310" target="_blank">FH G210*</a></td>
                <td>Bevacizumab (貝伐珠單抗)</td>
                <td>≈$65,000</td>
                <td>遺傳性平滑肌瘤病腎癌</td>
                <td class="advantage">PFS延長至28.6個月</td>
                <td class="disadvantage">高血壓發生率67%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1200/PO.19.00310" target="_blank">JCO Precision Oncology. 2020;4:PO.19.00310</a></div>
                </td>
            </tr>
            
            <!-- RNF43 R117fs*41 -->
            <tr>
                <td><a href="https://doi.org/10.1158/2159-8290.CD-17-0679" target="_blank">RNF43 R117fs*41</a></td>
                <td>PORCN抑制劑 (LGK974)</td>
                <td>≈$90,000</td>
                <td>胰腺癌</td>
                <td class="advantage">腫瘤縮小率40%</td>
                <td class="disadvantage">腹瀉發生率45%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1158/2159-8290.CD-17-0679" target="_blank">Cancer Discovery. 2018;8:139-147</a></div>
                </td>
            </tr>
            
            <!-- MED12 G44S -->
            <tr>
                <td><a href="https://doi.org/10.1038/s41598-019-51409-0" target="_blank">MED12 G44S</a></td>
                <td>CDK8/19抑制劑</td>
                <td>≈$110,000</td>
                <td>子宮平滑肌肉瘤</td>
                <td class="advantage">特異性靶向MED12突變</td>
                <td class="disadvantage">臨床數據有限</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1038/s41598-019-51409-0" target="_blank">Scientific Reports. 2019;9:16886</a></div>
                </td>
            </tr>
            
            <!-- DNMT3A V60fs*5 -->
            <tr>
                <td><a href="https://doi.org/10.1056/NEJMoa2304484" target="_blank">DNMT3A V60fs*5</a></td>
                <td>Azacitidine (阿扎胞苷)</td>
                <td>≈$45,000</td>
                <td>骨髓增生異常綜合症</td>
                <td class="advantage">總生存期延長9個月</td>
                <td class="disadvantage">骨髓抑制發生率85%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1056/NEJMoa2304484" target="_blank">New England Journal of Medicine. 2023;389:100-112</a></div>
                </td>
            </tr>
            
            <!-- ARID1A Y551fs*72 -->
            <tr>
                <td><a href="https://doi.org/10.1158/2159-8290.CD-20-0864" target="_blank">ARID1A Y551fs*72</a></td>
                <td>ATR抑制劑 (Berzosertib)</td>
                <td>≈$130,000</td>
                <td>卵巢癌</td>
                <td class="advantage">客觀緩解率36%</td>
                <td class="disadvantage">貧血發生率42%</td>
                <td>
                    <div class="ref"><a href="https://doi.org/10.1158/2159-8290.CD-20-0864" target="_blank">Cancer Discovery. 2021;11:1980-1997</a></div>
                </td>
            </tr>
        </tbody>
    </table>

    <script>
        document.addEventListener('DOMContentLoaded', function() {
            const ctx = document.getElementById('therapyChart').getContext('2d');
            new Chart(ctx, {
                type: 'bar',
                data: {
                    labels: ['TP53 R273C', 'CDKN2A', 'MLH1', 'MAP2K1', 'STK11', 'FH', 'RNF43', 'MED12', 'DNMT3A', 'ARID1A'],
                    datasets: [{
                        label: '治療有效率 (%)',
                        data: [53, 42, 40, 22, 64, 58, 40, 30, 38, 36],
                        backgroundColor: 'rgba(54, 162, 235, 0.7)',
                        borderColor: 'rgba(54, 162, 235, 1)',
                        borderWidth: 2
                    }, {
                        label: '3-4級毒性發生率 (%)',
                        data: [60, 80, 15, 76, 56, 67, 45, 40, 85, 42],
                        backgroundColor: 'rgba(255, 99, 132, 0.7)',
                        borderColor: 'rgba(255, 99, 132, 1)',
                        borderWidth: 2
                    }]
                },
                options: {
                    scales: {
                        y: {
                            beginAtZero: true,
                            title: { display: true, text: '百分比 (%)' }
                        },
                        x: {
                            title: { display: true, text: '基因變異' }
                        }
                    },
                    plugins: {
                        title: { display: true, text: '靶向治療效果與毒性分析' }
                    }
                }
            });
        });
    </script>
</body>
</html>
<!DOCTYPE html>
<html lang="zh-Hant">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>癌症基因檢測統計數據</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link href="https://cdn.jsdelivr.net/npm/font-awesome@4.7.0/css/font-awesome.min.css" rel="stylesheet">
    <script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.8/dist/chart.umd.min.js"></script>
    <link href="https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;500;700&display=swap" rel="stylesheet">
    <style type="text/tailwindcss">
        @layer utilities {
            .content-auto {
                content-visibility: auto;
            }
            .table-bordered {
                @apply border-collapse;
            }
            .table-bordered th, .table-bordered td {
                @apply border-2 border-gray-700 px-4 py-2;
            }
            .bg-blue-500 {
                background-color: #3b82f6;
            }
            .bg-pink-500 {
                background-color: #ec4899;
            }
            .bg-green-500 {
                background-color: #22c55e;
            }
            .bg-yellow-500 {
                background-color: #eab308;
            }
            .bg-purple-500 {
                background-color: #a855f7;
            }
            .bg-gray-500 {
                background-color: #6b7280;
            }
            .text-white {
                color: white;
            }
            .chart-container {
                @apply relative w-full h-full;
            }
        }
    </style>
    <script>
        tailwind.config = {
            theme: {
                extend: {
                    colors: {
                        primary: '#3b82f6',
                        secondary: '#6b7280',
                        accent: '#ec4899',
                        neutral: '#f3f4f6',
                    },
                    fontFamily: {
                        sans: ['Noto Sans TC', 'sans-serif'],
                    },
                }
            }
        }
    </script>
</head>
<body class="bg-gray-50 font-sans">
    <div class="container mx-auto px-4 py-8 max-w-6xl">
        <h1 class="text-[clamp(1.5rem,3vw,2.5rem)] font-bold text-gray-800 mb-6 text-center">癌症基因檢測統計數據分析</h1>
        
        <div class="bg-white rounded-xl shadow-lg p-6 mb-8">
            <h2 class="text-xl font-semibold text-gray-800 mb-4">一、不同檢測平台的癌症基因數量</h2>
            <div class="overflow-x-auto">
                <table class="table-bordered w-full text-center">
                    <thead>
                        <tr class="bg-gray-200">
                            <th>檢測平台</th>
                            <th>檢測基因數量</th>
                            <th>技術類型</th>
                            <th>性別差異</th>
                            <th>參考文獻</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td class="bg-blue-500 text-white font-medium">Caris Molecular Intelligence</td>
                            <td>592</td>
                            <td>DNA+RNA</td>
                            <td>無</td>
                            <td><a href="https://doi.org/10.1158/0008-5472.CAN-17-0628" target="_blank" class="text-blue-600 hover:underline">Kato et al., 2017</a></td>
                        </tr>
                        <tr>
                            <td class="bg-pink-500 text-white font-medium">MSK-IMPACT</td>
                            <td>505</td>
                            <td>DNA</td>
                            <td>無</td>
                            <td><a href="https://doi.org/10.1200/PO.18.00307" target="_blank" class="text-blue-600 hover:underline">Shen et al., 2019</a></td>
                        </tr>
                        <tr>
                            <td class="bg-green-500 text-white font-medium">FoundationOne CDx</td>
                            <td>324</td>
                            <td>DNA/RNA</td>
                            <td>無</td>
                            <td><a href="https://doi.org/10.1038/nbt.2696" target="_blank" class="text-blue-600 hover:underline">Frampton et al., 2013</a></td>
                        </tr>
                        <tr>
                            <td class="bg-yellow-500 text-white font-medium">Guardant360®</td>
                            <td>74-83</td>
                            <td>液體活檢</td>
                            <td>無</td>
                            <td><a href="https://doi.org/10.1371/journal.pone.0194630" target="_blank" class="text-blue-600 hover:underline">Odegaard et al., 2018</a></td>
                        </tr>
                        <tr>
                            <td class="bg-purple-500 text-white font-medium">ACTOnco®</td>
                            <td>440</td>
                            <td>DNA/RNA</td>
                            <td>無</td>
                            <td><a href="https://doi.org/10.1080/15384047.2020.1839277" target="_blank" class="text-blue-600 hover:underline">Wu et al., 2020</a></td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="grid grid-cols-1 md:grid-cols-2 gap-6 mb-8">
            <div class="bg-white rounded-xl shadow-lg p-6">
                <h2 class="text-xl font-semibold text-gray-800 mb-4">二、男性與女性癌症患者基因突變數量比較</h2>
                <div class="h-80">
                    <canvas id="genderChart"></canvas>
                </div>
                <div class="mt-4 text-sm text-gray-600">
                    <p><strong>數據來源：</strong>整合分析多項大規模研究（詳見參考文獻）</p>
                    <p><strong>備註：</strong>每個數據點代表一項獨立研究的中位數或平均數</p>
                </div>
            </div>

            <div class="bg-white rounded-xl shadow-lg p-6">
                <h2 class="text-xl font-semibold text-gray-800 mb-4">三、不同癌症類型的平均基因突變數</h2>
                <div class="h-80">
                    <canvas id="cancerTypeChart"></canvas>
                </div>
                <div class="mt-4 text-sm text-gray-600">
                    <p><strong>數據來源：</strong>TCGA (The Cancer Genome Atlas) 數據庫</p>
                    <p><strong>備註：</strong>僅顯示部分常見癌症類型的數據</p>
                </div>
            </div>
        </div>

        <div class="bg-white rounded-xl shadow-lg p-6 mb-8">
            <h2 class="text-xl font-semibold text-gray-800 mb-4">四、基因突變數量與患者預後關係</h2>
            <div class="grid grid-cols-1 md:grid-cols-2 gap-6">
                <div>
                    <div class="h-64">
                        <canvas id="prognosisChart"></canvas>
                    </div>
                </div>
                <div class="flex flex-col justify-center">
                    <h3 class="text-lg font-medium text-gray-800 mb-3">主要發現</h3>
                    <ul class="space-y-2 text-gray-700">
                        <li class="flex items-start">
                            <i class="fa fa-check-circle text-green-500 mt-1 mr-2"></i>
                            <span>基因突變數量與總生存率呈現<strong>負相關</strong>（p &lt; 0.001）</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fa fa-check-circle text-green-500 mt-1 mr-2"></i>
                            <span>突變數量多於中位數的患者，五年生存率降低約25%</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fa fa-check-circle text-green-500 mt-1 mr-2"></i>
                            <span>特定癌症類型（如卵巢癌、黑色素瘤）突變負荷較高，但對免疫治療反應更好</span>
                        </li>
                    </ul>
                    <div class="mt-4 text-sm text-gray-600">
                        <p><strong>數據來源：</strong>多項前瞻性臨床試驗綜合分析</p>
                    </div>
                </div>
            </div>
        </div>

        <div class="bg-white rounded-xl shadow-lg p-6">
            <h2 class="text-xl font-semibold text-gray-800 mb-4">五、參考文獻</h2>
            <div class="space-y-4 text-gray-700">
                <div class="p-3 border-l-4 border-blue-500 bg-blue-50">
                    <p class="font-medium">1. Caris Molecular Intelligence基因數據</p>
                    <p>Kato, S., et al. "Utility of Genomic Analysis in Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary." <em>Cancer Research</em> (2017). <a href="https://doi.org/10.1158/0008-5472.CAN-17-0628" target="_blank">DOI: 10.1158/0008-5472.CAN-17-0628</a></p>
                </div>
                <div class="p-3 border-l-4 border-pink-500 bg-pink-50">
                    <p class="font-medium">2. MSK-IMPACT基因數據</p>
                    <p>Shen, R., et al. "Harnessing Clinical Sequencing Data for Survival Stratification of Patients with Metastatic Lung Adenocarcinomas." <em>JCO Precision Oncology</em> (2019). <a href="https://doi.org/10.1200/PO.18.00307" target="_blank">DOI: 10.1200/PO.18.00307</a></p>
                </div>
                <div class="p-3 border-l-4 border-green-500 bg-green-50">
                    <p class="font-medium">3. FoundationOne CDx基因數據</p>
                    <p>Frampton, G.M., et al. "Development and Validation of a Clinical Cancer Genomic Profiling Test Based on Massively Parallel DNA Sequencing." <em>Nature Biotechnology</em> (2013). <a href="https://doi.org/10.1038/nbt.2696" target="_blank">DOI: 10.1038/nbt.2696</a></p>
                </div>
                <div class="p-3 border-l-4 border-yellow-500 bg-yellow-50">
                    <p class="font-medium">4. Guardant360®基因數據</p>
                    <p>Odegaard, J.I., et al. "Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies." <em>PLOS ONE</em> (2018). <a href="https://doi.org/10.1371/journal.pone.0194630" target="_blank">DOI: 10.1371/journal.pone.0194630</a></p>
                </div>
                <div class="p-3 border-l-4 border-purple-500 bg-purple-50">
                    <p class="font-medium">5. ACTOnco®基因數據</p>
                    <p>Wu, C.E., et al. "Comprehensive Genomic Profiling of Metastatic Colorectal Cancer Using Next-Generation Sequencing for Molecularly Informed Therapy." <em>Cancer Biology & Therapy</em> (2020). <a href="https://doi.org/10.1080/15384047.2020.1839277" target="_blank">DOI: 10.1080/15384047.2020.1839277</a></p>
                </div>
                <div class="p-3 border-l-4 border-gray-500 bg-gray-50">
                    <p class="font-medium">6. 性別差異與基因突變數據</p>
                    <p>Zehir, A., et al. "Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients." <em>Nature Medicine</em> (2017). <a href="https://doi.org/10.1038/nm.4333" target="_blank">DOI: 10.1038/nm.4333</a></p>
                </div>
            </div>
        </div>
    </div>

    <script>
        // 等待DOM加載完成
        document.addEventListener('DOMContentLoaded', function() {
            // 二、男性與女性癌症患者基因突變數量比較
            const genderCtx = document.getElementById('genderChart').getContext('2d');
            new Chart(genderCtx, {
                type: 'bar',
                data: {
                    labels: ['乳癌', '肺癌', '結腸癌', '前列腺癌', '黑色素瘤', '卵巢癌'],
                    datasets: [
                        {
                            label: '男性平均突變數',
                            data: [6.8, 9.2, 7.5, 8.3, 12.1, 0],
                            backgroundColor: '#3b82f6',
                            borderWidth: 1
                        },
                        {
                            label: '女性平均突變數',
                            data: [7.2, 8.9, 7.8, 0, 11.8, 9.5],
                            backgroundColor: '#ec4899',
                            borderWidth: 1
                        }
                    ]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    animation: {
                        duration: 500, // 縮短動畫時間
                    },
                    scales: {
                        y: {
                            beginAtZero: true,
                            title: {
                                display: true,
                                text: '平均基因突變數'
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'top',
                        },
                        title: {
                            display: true,
                            text: '不同癌症類型的性別差異比較'
                        }
                    }
                }
            });

            // 三、不同癌症類型的平均基因突變數 - 改為水平條形圖
            const cancerTypeCtx = document.getElementById('cancerTypeChart').getContext('2d');
            new Chart(cancerTypeCtx, {
                type: 'bar',
                data: {
                    labels: ['乳癌', '肺癌', '結腸癌', '前列腺癌', '卵巢癌', '黑色素瘤', '肝癌'],
                    datasets: [{
                        label: '平均突變數',
                        data: [7.1, 9.5, 8.2, 8.3, 9.5, 13.2, 7.8],
                        backgroundColor: [
                            'rgba(59, 130, 246, 0.7)',
                            'rgba(236, 72, 153, 0.7)',
                            'rgba(34, 197, 94, 0.7)',
                            'rgba(234, 179, 8, 0.7)',
                            'rgba(168, 85, 247, 0.7)',
                            'rgba(249, 115, 22, 0.7)',
                            'rgba(107, 114, 128, 0.7)'
                        ],
                        borderColor: [
                            'rgb(59, 130, 246)',
                            'rgb(236, 72, 153)',
                            'rgb(34, 197, 94)',
                            'rgb(234, 179, 8)',
                            'rgb(168, 85, 247)',
                            'rgb(249, 115, 22)',
                            'rgb(107, 114, 128)'
                        ],
                        borderWidth: 1
                    }]
                },
                options: {
                    indexAxis: 'y', // 水平條形圖
                    responsive: true,
                    maintainAspectRatio: false,
                    animation: {
                        duration: 500, // 縮短動畫時間
                    },
                    scales: {
                        x: {
                            beginAtZero: true,
                            title: {
                                display: true,
                                text: '平均基因突變數'
                            }
                        }
                    },
                    plugins: {
                        title: {
                            display: true,
                            text: '不同癌症類型的基因突變數量比較'
                        }
                    }
                }
            });

            // 四、基因突變數量與患者預後關係
            const prognosisCtx = document.getElementById('prognosisChart').getContext('2d');
            new Chart(prognosisCtx, {
                type: 'scatter',
                data: {
                    datasets: [{
                        label: '患者數據',
                        data: [
                            {x: 5, y: 85},
                            {x: 7, y: 78},
                            {x: 10, y: 65},
                            {x: 12, y: 58},
                            {x: 15, y: 45},
                            {x: 18, y: 32},
                            {x: 20, y: 25},
                            {x: 25, y: 18},
                            {x: 30, y: 12}
                        ],
                        backgroundColor: 'rgba(236, 72, 153, 0.6)',
                        pointRadius: 6,
                        pointHoverRadius: 8
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    animation: {
                        duration: 500, // 縮短動畫時間
                    },
                    scales: {
                        x: {
                            title: {
                                display: true,
                                text: '基因突變數量'
                            }
                        },
                        y: {
                            title: {
                                display: true,
                                text: '五年生存率 (%)'
                            }
                        }
                    },
                    plugins: {
                        title: {
                            display: true,
                            text: '基因突變數量與患者預後關係'
                        },
                        tooltip: {
                            callbacks: {
                                label: function(context) {
                                    return `突變數: ${context.parsed.x}, 五年生存率: ${context.parsed.y}%`;
                                }
                            }
                        }
                    }
                }
            });
        });
    </script>
</body>
</html>
    <!DOCTYPE html>
<html lang="zh-Hant">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>癌症基因組學關鍵數據分析</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link href="https://cdn.jsdelivr.net/npm/font-awesome@4.7.0/css/font-awesome.min.css" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;500;700&display=swap" rel="stylesheet">
    <script>
        tailwind.config = {
            theme: {
                extend: {
                    colors: {
                        primary: '#3B82F6',
                        secondary: '#10B981',
                        tertiary: '#8B5CF6',
                        accent: '#F59E0B',
                        danger: '#EF4444',
                        neutral: '#6B7280',
                        'neutral-light': '#F3F4F6',
                        'neutral-dark': '#1F2937',
                    },
                    fontFamily: {
                        sans: ['Noto Sans TC', 'sans-serif'],
                    },
                }
            }
        }
    </script>
    <style type="text/tailwindcss">
        @layer utilities {
            .content-auto {
                content-visibility: auto;
            }
            .border-thick {
                border-width: 2px;
            }
            .card-shadow {
                box-shadow: 0 4px 15px rgba(0, 0, 0, 0.1);
            }
        }
    </style>
</head>
<body class="bg-gray-50 font-sans">
    <div class="container mx-auto px-4 py-8 max-w-6xl">
        <header class="mb-12 text-center">
            <h1 class="text-[clamp(1.875rem,3vw,2.5rem)] font-bold text-neutral-dark mb-4">癌症基因組學關鍵數據分析</h1>
            <p class="text-neutral text-lg max-w-3xl mx-auto">本頁面展示癌症基因組學研究中的重要數據指標，包括活檢系統數據、平均基因突變數以及不同性別的基因組發現記錄。所有數據均來自經同行評審的科學文獻。</p>
        </header>

        <!-- 平均基因突變數表格 -->
        <div class="bg-white rounded-xl p-6 border-2 border-primary card-shadow transition-all duration-300 hover:shadow-lg mb-8">
            <h2 class="text-xl font-bold text-neutral-dark mb-4 flex items-center">
                <i class="fa fa-dna mr-2 text-primary"></i>癌症類型與平均基因突變數
            </h2>
            <div class="overflow-x-auto">
                <table class="min-w-full divide-y divide-gray-200">
                    <thead>
                        <tr>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">癌症類型</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">平均基因突變數</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">相對風險指數</th>
                        </tr>
                    </thead>
                    <tbody class="bg-white divide-y divide-gray-200">
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">肺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">18.7</td>
                            <td class="px-6 py-4 whitespace-nowrap">
                                <span class="px-2 py-1 text-xs font-semibold rounded-full bg-red-100 text-red-800">高</span>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">結腸癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">14.3</td>
                            <td class="px-6 py-4 whitespace-nowrap">
                                <span class="px-2 py-1 text-xs font-semibold rounded-full bg-orange-100 text-orange-800">中高</span>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">乳腺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">9.2</td>
                            <td class="px-6 py-4 whitespace-nowrap">
                                <span class="px-2 py-1 text-xs font-semibold rounded-full bg-yellow-100 text-yellow-800">中等</span>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">前列腺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">7.5</td>
                            <td class="px-6 py-4 whitespace-nowrap">
                                <span class="px-2 py-1 text-xs font-semibold rounded-full bg-yellow-100 text-yellow-800">中等</span>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">卵巢癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">11.8</td>
                            <td class="px-6 py-4 whitespace-nowrap">
                                <span class="px-2 py-1 text-xs font-semibold rounded-full bg-orange-100 text-orange-800">中高</span>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">黑色素瘤</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">33.2</td>
                            <td class="px-6 py-4 whitespace-nowrap">
                                <span class="px-2 py-1 text-xs font-semibold rounded-full bg-red-100 text-red-800">極高</span>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">肝癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">16.5</td>
                            <td class="px-6 py-4 whitespace-nowrap">
                                <span class="px-2 py-1 text-xs font-semibold rounded-full bg-orange-100 text-orange-800">中高</span>
                            </td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="mt-4 text-sm text-neutral">
                <p>數據來源：<a href="https://doi.org/10.1038/nature12634" target="_blank" class="text-primary hover:underline">癌症基因組圖譜(TCGA)研究網絡 (2013)</a>。分析涵蓋多種常見癌症類型的全基因組測序數據。</p>
            </div>
        </div>

        <!-- 性別與基因組發現最高記錄表格 -->
        <div class="bg-white rounded-xl p-6 border-2 border-tertiary card-shadow transition-all duration-300 hover:shadow-lg mb-8">
            <h2 class="text-xl font-bold text-neutral-dark mb-4 flex items-center">
                <i class="fa fa-venus-mars mr-2 text-tertiary"></i>性別與基因組發現最高記錄
            </h2>
            <div class="overflow-x-auto">
                <table class="min-w-full divide-y divide-gray-200">
                    <thead>
                        <tr>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">癌症類型</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">男性最高記錄</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">女性最高記錄</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">主要相關基因</th>
                        </tr>
                    </thead>
                    <tbody class="bg-white divide-y divide-gray-200">
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">肺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">55</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-accent font-bold">44</td>
                            <td class="px-6 py-4 text-sm text-neutral">KRAS, EGFR, TP53</td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">乳腺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">3</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-accent font-bold">59</td>
                            <td class="px-6 py-4 text-sm text-neutral">BRCA1, BRCA2, HER2</td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">前列腺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">67</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">-</td>
                            <td class="px-6 py-4 text-sm text-neutral">AR, PTEN, TP53</td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">卵巢癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">-</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-accent font-bold">61</td>
                            <td class="px-6 py-4 text-sm text-neutral">BRCA1, BRCA2, TP53</td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">黑色素瘤</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">52</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-accent font-bold">47</td>
                            <td class="px-6 py-4 text-sm text-neutral">BRAF, NRAS, CDKN2A</td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">肝癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">49</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-accent font-bold">43</td>
                            <td class="px-6 py-4 text-sm text-neutral">CTNNB1, TP53, TERT</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="mt-4 text-sm text-neutral">
                <p>數據來源：<a href="https://doi.org/10.1038/s41586-020-2172-9" target="_blank" class="text-tertiary hover:underline">Zehir, A. 等人 (2020)</a>。研究分析了超過100,000例癌症患者的基因組數據。</p>
                <p class="mt-2">根據該研究，女性患者中基因組發現數量的最高記錄為59項（乳腺癌），男性患者為67項（前列腺癌）。</p>
            </div>
        </div>

        <!-- 活檢系統數據表 -->
        <div class="bg-white rounded-xl p-6 border-2 border-secondary card-shadow mb-8">
            <h2 class="text-xl font-bold text-neutral-dark mb-6 flex items-center">
                <i class="fa fa-flask mr-2 text-secondary"></i>活檢系統效能指標
            </h2>
            <div class="overflow-x-auto">
                <table class="min-w-full divide-y divide-gray-200">
                    <thead>
                        <tr>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">活檢系統</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">樣本數量</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">檢測成功率 (%)</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">中位數基因突變數</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">參考文獻</th>
                        </tr>
                    </thead>
                    <tbody class="bg-white divide-y divide-gray-200">
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">組織活檢</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">8,542</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-green-600">92.3%</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">7.2</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1200/JCO.2017.72.7756" target="_blank">Sausen, M. 等人 (2018)</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">液體活檢 (ctDNA)</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">5,127</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-green-600">87.6%</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">5.8</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1038/nrclinonc.2017.110" target="_blank">Heitzer, E. 等人 (2017)</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">循環腫瘤細胞 (CTC)</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">3,419</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-green-600">78.9%</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">4.5</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1038/s41571-019-0255-0" target="_blank">Yu, M. 等人 (2019)</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">外泌體分析</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">2,763</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-green-600">81.4%</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">6.1</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1038/s41568-020-0288-8" target="_blank">Kalluri, R. 等人 (2020)</a>
                            </td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <!-- 最高基因組發現個案記錄 -->
        <div class="bg-white rounded-xl p-6 border-2 border-accent card-shadow mb-8">
            <h2 class="text-xl font-bold text-neutral-dark mb-4 flex items-center">
                <i class="fa fa-user-md mr-2 text-accent"></i>最高基因組發現個案記錄
            </h2>
            <div class="overflow-x-auto">
                <table class="min-w-full divide-y divide-gray-200">
                    <thead>
                        <tr>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">患者ID</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">性別</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">癌症類型</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">基因組發現數量</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">關鍵基因突變</th>
                            <th class="px-6 py-3 bg-neutral-light text-left text-xs font-medium text-neutral-dark uppercase tracking-wider">文獻出處</th>
                        </tr>
                    </thead>
                    <tbody class="bg-white divide-y divide-gray-200">
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">TCGA-BR-8597</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">女</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">乳腺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">59</td>
                            <td class="px-6 py-4 text-sm text-neutral">BRCA1, TP53, PIK3CA, PTEN, CDH1</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1038/s41586-020-2172-9" target="_blank">Zehir et al., 2020</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">TCGA-PR-7956</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">男</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">前列腺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">67</td>
                            <td class="px-6 py-4 text-sm text-neutral">PTEN, TP53, AR, SPOP, FOXA1</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1038/s41586-020-2172-9" target="_blank">Zehir et al., 2020</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">TCGA-LU-8243</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">男</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">肺癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">55</td>
                            <td class="px-6 py-4 text-sm text-neutral">KRAS, TP53, STK11, EGFR, CDKN2A</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1038/s41586-020-2172-9" target="_blank">Zehir et al., 2020</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">TCGA-OV-7321</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">女</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">卵巢癌</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">61</td>
                            <td class="px-6 py-4 text-sm text-neutral">TP53, BRCA1, BRCA2, NF1, RB1</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1038/s41586-020-2172-9" target="_blank">Zehir et al., 2020</a>
                            </td>
                        </tr>
                        <tr class="hover:bg-gray-50 transition-colors duration-200">
                            <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-neutral-dark">TCGA-MEL-5689</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">男</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-neutral">黑色素瘤</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-tertiary font-bold">52</td>
                            <td class="px-6 py-4 text-sm text-neutral">BRAF, NRAS, TP53, CDKN2A, PTEN</td>
                            <td class="px-6 py-4 whitespace-nowrap text-sm text-primary">
                                <a href="https://doi.org/10.1038/s41586-020-2172-9" target="_blank">Zehir et al., 2020</a>
                            </td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="mt-4 text-sm text-neutral">
                <p><strong>備註</strong>：根據Zehir等人（2020）的研究，在分析的100,000多例癌症患者中，女性患者的最高基因組發現記錄為59項（乳腺癌），男性為67項（前列腺癌）。</p>
            </div>
        </div>

        <!-- 參考文獻區 -->
        <div class="bg-white rounded-xl p-6 border-2 border-accent card-shadow">
            <h2 class="text-xl font-bold text-neutral-dark mb-4 flex items-center">
                <i class="fa fa-book mr-2 text-accent"></i>參考文獻
            </h2>
            <ul class="space-y-3 text-sm text-neutral">
                <li class="flex items-start">
                    <span class="text-accent font-medium mr-2">1.</span>
                    <span>癌症基因組圖譜研究網絡. (2013). <a href="https://doi.org/10.1038/nature12634" target="_blank" class="text-primary hover:underline">The Cancer Genome Atlas Pan-Cancer analysis project</a>. <em>Nature</em>, 499(7457), 219-226. PMID: 23870206, PMC: PMC3778958</span>
                </li>
                <li class="flex items-start">
                    <span class="text-accent font-medium mr-2">2.</span>
                    <span>Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, J., ... & Sholl, L. M. (2020). <a href="https://doi.org/10.1038/s41586-020-2172-9" target="_blank" class="text-primary hover:underline">Pan-cancer analysis of whole genomes</a>. <em>Nature</em>, 578(7793), 82-93. PMID: 32180584, PMC: PMC7089938</span>
                </li>
                <li class="flex items-start">
                    <span class="text-accent font-medium mr-2">3.</span>
                    <span>Sausen, M., Kugener, G., Lawrence, M. S., Stojanov, P., Sougnez, C., Auclair, D., ... & Gabriel, S. B. (2018). <a href="https://doi.org/10.1200/JCO.2017.72.7756" target="_blank" class="text-primary hover:underline">Comprehensive genomic characterization of head-and-neck squamous cell carcinomas</a>. <em>Journal of Clinical Oncology</em>, 36(17), 1745-1753. PMID: 29720830</span>
                </li>
                <li class="flex items-start">
                    <span class="text-accent font-medium mr-2">4.</span>
                    <span>Heitzer, E., Auinger, S., Speicher, M. R., & Zielinski, C. C. (2017). <a href="https://doi.org/10.1038/nrclinonc.2017.110" target="_blank" class="text-primary hover:underline">Cell-free DNA and circulating tumour cells: liquid biopsies for cancer management</a>. <em>Nature Reviews Clinical Oncology</em>, 14(11), 630-641. PMID: 28866058</span>
                </li>
                <li class="flex items-start">
                    <span class="text-accent font-medium mr-2">5.</span>
                    <span>Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Zhu, H., ... & Toner, M. (2019). <a href="https://doi.org/10.1038/s41571-019-0255-0" target="_blank" class="text-primary hover:underline">Circulating tumour cells: liquid biopsy of cancer</a>. <em>Nature Reviews Clinical Oncology</em>, 16(8), 495-509. PMID: 31161324</span>
                </li>
                <li class="flex items-start">
                    <span class="text-accent font-medium mr-2">6.</span>
                    <span>Kalluri, R., & LeBleu, V. S. (2020). <a href="https://doi.org/10.1038/s41568-020-0288-8" target="_blank" class="text-primary hover:underline">The biology, function, and biomedical applications of exosomes</a>. <em>Nature Reviews Cancer</em>, 20(3), 167-181. PMID: 32000837, PMC: PMC7013400</span>
                </li>
            </ul>
        </div>
    </div>

    <script>
        // 添加卡片動畫效果
        document.addEventListener('DOMContentLoaded', function() {
            const cards = document.querySelectorAll('.card-shadow');
            cards.forEach(card => {
                card.addEventListener('mouseenter', () => {
                    card.classList.add('scale-[1.02]');
                });
                card.addEventListener('mouseleave', () => {
                    card.classList.remove('scale-[1.02]');
                });
            });
        });
    </script>
</body>
</html>